col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Society of Hematology: Blood
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―06 COVID-19 as a potential trigger of complement-mediated atypical HUS. Carine El-Sissy, Antonin Saldman, Gilbert zanetta, Paula Vieira-Martins, Coralie Poulain, Raphaël Cauchois, et al. (+12)
2 [GO] 2021―Aug―02 Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy Binod Dhakal, Sameem M Abedin, Timothy S. Fenske, Saurabh Chhabra, Nathan Ledeboer, Parameswaran Hari, Mehdi Hamadani
3 [GO] 2021―Jul―23 COVID-19 in patients with CLL: improved survival outcomes and update on management strategies Lindsey Elizabeth Roeker, Toby Andrew Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids, et al. (+45)
4 [GO] 2021―Jul―23 Immune Thrombocytopenic Purpura after vaccination with COVID-19 Vaccine (ChAdOx1 nCov-19) Finn-Ole Paulsen, Christoph Schaefers, Florian Langer, Christian Frenzel, Ulrich Wenzel, Felicitas E. Hengel, et al. (+2)
5 [GO] 2021―Jul―19 Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein Andreas Greinacher, Kathleen Selleng, Julia Mayerle, Raghavendra Palankar, Jan Wesche, Sven Reiche, et al. (+20)
6 [GO] 2021―Jul―15 Thrombosis with COVID-19: kids get it too Cliff Takemoto
7 [GO] 2021―Jul―01 Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies Paola Ghione, Juan J Gu, Kristopher Attwood, Pallawi Torka, Shipra Goel, Suchitra Sundaram, et al. (+16)
8 [GO] 2021―Jun―10 Efficacy of COVID-19 vaccine in patients with CLL
9 [GO] 2021―Jun―10 Vaccination against COVID-19: a challenge in CLL Barbara Eichhorst
10 [GO] 2021―Jun―02 SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation by activation of acid sphingomyelinase Jue Wang, Usha R. Pendurthi, Guohua Yi, L. Vijaya Mohan Rao
11 [GO] 2021―May―20 Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry Dimitrios Giannis, Steven L. Allen, James Tsang, Sarah Flint, Tamir Pinhasov, Stephanie Williams, et al. (+22)
12 [GO] 2021―May―14 Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 Thomas Thiele, Lena Ulm, Silva Holtfreter, Linda Schönborn, Sven Olaf Kuhn, Christian Scheer, et al. (+7)
13 [GO] 2021―May―05 COVID-19 Vaccines Induce Severe Hemolysis in Paroxysmal Nocturnal Hemoglobinuria Gloria Frances Gerber, Xuan Yuan, Jia Yu, Benjamin A.Y. Cher, Evan M. Braunstein, Shruti Chaturvedi, Robert A. Brodsky
14 [GO] 2021―May―05 A Flow cytometric assay to detect platelet activating antibodies in VITT after ChAdOx1 nCov-19 vaccination Stefan Handtke, Martina Wolff, Carlo Zaninetti, Jan Wesche, Linda Schönborn, Konstanze Aurich, et al. (+5)
15 [GO] 2021―Apr―28 Prothrombotic immune thrombocytopenia after COVID-19 vaccine Andreas Tiede, Ulrich J Sachs, Andreas Czwalinna, Sonja Werwitzke, Rolf Bikker, Joachim K Krauss, et al. (+6)
16 [GO] 2021―Apr―25 Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C Hilary Baker Whitworth, Sarah E Sartain, Riten Kumar, Katherine Armstrong, Lance Ballester, Marisol Betensky, et al. (+14)
17 [GO] 2021―Apr―17 Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia Yair Herishanu, Irit Avivi, Anat Aharon, Gabi Shefer, Shai Levi, Yotam Bronstein, et al. (+7)
18 [GO] 2021―Apr―17 Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose Evangelos Terpos, Ioannis P Trougakos, Maria Gavriatopoulou, Ioannis Papassotiriou, Aimilia D Sklirou, Ioannis Ntanasis-Stathopoulos, et al. (+4)
19 [GO] 2021―Mar―18 Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood. 2020;135(21):1912-1915.
20 [GO] 2021―Feb―25 Another front in COVID-19’s perfect storm Shawn M. Jobe, Renren Wen
21 [GO] 2021―Feb―08 COVID-19 and Hematologic Malignancies: Single Institution Analysis Nwabundo Anusim, Melanie Smalley, Markie Sue Zimmer, Doyle Lang, Vishal Jindal, Hycienth O Ahaneku, et al. (+3)
22 [GO] 2021―Feb―08 Association of Anticoagulant Use with COVID-19 Diagnosis Juraj Kavecansky, Jennifer R Dusendang, Jahan Tavakoli, Julie Schmittdiel, Gwendolyn Ho, Jodi Loyles, Ashok Pai
23 [GO] 2021―Feb―08 Covid-19 Disease Is Not Associated with Venous Thromboembolism in a Cohort of Patients in Jeddah, Saudi Arabia Fatemah Kamel, Rania Magadmi, Sulafa Alqutub, Maha A. Badawi, Fatin Al-Sayes, Mazen Badawi, et al. (+2)
24 [GO] 2021―Feb―08 Patient-Focused Benefits of at-Home Versus in-Clinic Administration of Cancer Therapy: New Considerations for the COVID-19 Era Karen E. Sandman, Timothy J. Bell
25 [GO] 2021―Feb―08 Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN) Minoo Battiwalla, Carlos Bachier, Vikas Bhushan, Michael J. Eckrich, Alireza Eghtedar, Haydar Frangoul, et al. (+11)
26 [GO] 2021―Feb―08 Delivering Systemic Anti-Cancer Treatment Via Another Route of Administration As an Option to Reduce Exposure to COVID-19 in Patients with Multiple Myeloma in the UK Holly Cranmer, Tanja Podkonjak, Eugene Benson, Jonathon Dabora, Graham H Jackson
27 [GO] 2021―Feb―08 ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population Sonal Paul, Nisha Patel, Chathula Kumarasinghe, Neil Nimkar, Angelica Singh, Nivetha Vishnuvardhan, et al. (+10)
28 [GO] 2021―Feb―08 Association of Blood Type on Clinical Outcomes in Black/African Americans Hospitalized for COVID-19 Infection Yan Cheng, Sharif Mohammed, Alexis Okoh, Ki (Steve) Lee, Corinne Raczek, Amin Krushna, et al. (+2)
29 [GO] 2021―Feb―08 Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection Carlos A Lopez, David Chitty, Jeffrey Chi, Wasif Saif, Bradley Goldberg
30 [GO] 2021―Feb―08 Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies Elizabeth Behrens, Anne Timmermann, Alexander Yerkan, Deborah A. Katz, Agne Paner, Melissa C. Larson, et al. (+9)
31 [GO] 2021―Feb―08 Prediction of COVID-19 Mortality in Patients with Cancer Simon Mantha, Justin Jee, Gerald A. Soff, Melissa S. Pessin
32 [GO] 2021―Feb―08 Clinical Impact of COVID-19 on Anticoagulation Management at the William S. Middleton Memorial Veterans Hospital Hannah Hecht, Allison B Riendeau, Jillian Kolasinski, Cheryl Ray, Moniba Nazeef
33 [GO] 2021―Feb―08 Increased Productivity and Efficiency Among Cancer Center Clinical Trials Workforce during the COVID-19 Pandemic Kimberly C Jenkins, Emily C Zabor, Lindsey A. R. Mooney, Aaron T. Gerds, Kerry O'Hop, Makenzie Guy, et al. (+3)
34 [GO] 2021―Feb―08 A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic Helen Cashman, Eleni Mayson, David Kliman, Sue Vachalec, Jennifer Bell, Sam Milliken, et al. (+4)
35 [GO] 2021―Feb―08 Utilization of Telemedicine for Comprehensive Visits in Patients with Inherited Bleeding Disorders during the COVID-19 Pandemic Cassandra P Wang, Kelly Ann Bush, Rosalie Brooks, Katharine Farrow, Lizandra Gilsdorf, Fernanda Cortez, Courtney D Thornburg
36 [GO] 2021―Feb―08 Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience Giamal Edin Gmati, Nadine Mabsut, Zainab Matar, Mona Alshami, Husam Shahata, Areej Alkhesaifi, et al. (+9)
37 [GO] 2021―Feb―08 COVID-19 Pandemic Highlights Health Disparities in Latinos in San Diego Elisa Quiroz, David J Hermel, Samantha R Bagsic, Carrie L. Costantini, Anuj Mahindra, Alan Saven, et al. (+2)
38 [GO] 2021―Feb―08 Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients Angelica D'Aiello, Sumaira Zareef, Kith Pradhan, Amanda Lombardo, Fariha Khatun, Jennat Mustafa, et al. (+39)
39 [GO] 2021―Feb―08 Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore Cheryl XQ Lim, Chuen Wen Tan, Bingwen Eugene Fan, Winnie Teo, Moon Ley Tung, Humaira Shafi, et al. (+21)
40 [GO] 2021―Feb―08 COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients Amardeep Kalsi, Sana Irfan Khan, Asad Rehman, Neil Nimkar, Angelica Singh, Nivetha Vishnuvardhan, et al. (+11)
41 [GO] 2021―Feb―08 Improvement in Clinic Efficiency, Patient Satisfaction, and Overcoming Unique Challenges in the Era of COVID-19 with Implementation of Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis David Hughes, Radhika Jhaveri, Bhavesh Shah, Frances Blevins, Alexamil Rodriguez, Shayna Sarosiek, et al. (+3)
42 [GO] 2021―Feb―08 Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution Viola Maria Popov, Lelia Iliescu, Marius Ioan Balea, Daniela Georgeta Georgescu, Mihaela Andreescu, Horia Bumbea, et al. (+21)
43 [GO] 2021―Feb―08 Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, Richard McNally, Adrianne Kelly, Marco Romano, et al. (+5)
44 [GO] 2021―Feb―08 Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19? Imran K Tailor, Syed Y Altaf, Nawal F Alshehry, Alaa M Alser, Mohammed Marei, Mansour Alfayez, et al. (+2)
45 [GO] 2021―Feb―08 A Machine Learning Approach for the Differential Diagnosis between Sars-COV19 Infection and Influenza Viruses with Hematological Morphologic DATA (CELL MORPHOLOGIC DATA) Fernando Calvo Boyero, Sandra Gomez Gomez Rojas, Gloria Perez Segura, Ana Lopez Jimenez, Miguel Pedrera Jimenez, Gonzalo Carreño Gomez-Tarragona, et al. (+2)
46 [GO] 2021―Feb―08 Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic Alberto Mussetti, Maria Queralt Salas Gay, Maria Condom, Maite Antonio, Cristian Ochoa, Iulia Ivan, et al. (+6)
47 [GO] 2021―Feb―08 Critical Care Support Improves Outcome of Haematology Admissions: A Retrospective Analysis during Covid Pandemic from UK Richard Whitmill, Supratik Basu, Anandadeep Mandal, Ubon Usung, Arwa Babai, Mustafa Mohamed
48 [GO] 2021―Feb―08 Perception and Psychological Help Seeking Behaviour Among Hematology Healthcare Workers during the COVID19 Pandemic in India Lakshmi Prabha, Kishore Kumar
49 [GO] 2021―Feb―08 COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy Molly Daughety, Thomas L. Ortel, Erin Frost, Andrew Morgan, Chester Kao, Joyce Hwang, et al. (+2)
50 [GO] 2021―Feb―08 Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection Pável E Olivera, Desiree Campoy, César A Velasquez, Katia Flores, Tania Canals, Erik A Johansson, et al. (+4)
51 [GO] 2021―Feb―08 Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic Valentina Baez Sosa, Cathy Conry-Cantilena, Glenn Wortmann, Emily R Fischer, Brandon G Clark, Lorraine Wyne, Aarthi Shenoy
52 [GO] 2021―Feb―08 Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients Kelly L. Bolton, Michael Foote, Justin Jee, Anton Safonov, Ryan Ptashkin, Sean Devlin, et al. (+13)
53 [GO] 2021―Feb―08 Myelodysplastic Syndromes (MDS) & COVID-19: Clinical Experience from the US Epicenter of the Pandemic Jonathan Feld, Erin P. Demakos, Rosalie Odchimar-Reissig, Douglas Tremblay, Saudia Alli, Darshanie Sewah, et al. (+2)
54 [GO] 2021―Feb―08 Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia Simone Claudiani, Carolina Rosadas, Myra McClure, Maryam Khan, Richard S. Tedder, Andrew J. Innes, et al. (+2)
55 [GO] 2021―Feb―08 COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study Guilherme Fleury Perini, Juan Alejandro Ospina Idarraga, Maria Alejandra Torres Viera, Brady E Beltran, Denisse A. Castro, Victoria Otero, et al. (+34)
56 [GO] 2021―Feb―08 Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review Nicolas Galllastegui Crestani, Jenny Y Zhou, Annette von Drygalski, Timothy A Morris
57 [GO] 2021―Feb―08 Sars-Cov-2 Spike Protein Induces Cellular Changes in Primitive and Mature Hematopoietic Cells James Ropa, Scott Cooper, Maegan L. Capitano, Hal E. Broxmeyer
58 [GO] 2021―Feb―08 Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients Jeanne M. Palmer, Carolyn Mead-Harvey, Claire Harrison, Amylou C. Dueck, Ryan Eckert, Heidi E. Kosiorek, et al. (+25)
59 [GO] 2021―Feb―08 Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care Perla R. Colunga Pedraza, Julia Esther Colunga Pedraza, Andres Gomez-De Leon, Mónica Bustillos Muñoz, Karen Lorena Osorno-Rodriguez, Jose Angel Hawing, et al. (+5)
60 [GO] 2021―Feb―07 COVID-19 Infection in Patients with Paroxysmal Nocturnal Hemoglobinuria in Italy Wilma Barcellini, Bruno Fattizzo, Luisa Quattrocchi, Juri Alessandro Giannotta, Semra Aydin, Federica Barone, et al. (+6)
61 [GO] 2021―Feb―07 Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic Andrea Nowlin, Kristina Lai, Alexander Maillis, Patricia Waters, Beatrice Gee, Peter A. Lane
62 [GO] 2021―Feb―07 Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic Jennifer G. Davila, W. Beau Mitchell, Kerry A Morrone, Ellen J Silver, Caterina P Minniti, Henny H. Billett, et al. (+3)
63 [GO] 2021―Feb―07 COVID-19: B-Cell Depletion and Sepsis Related Changes in Bone Marrow and Spleen Jana Ihlow, Ann-Christin von-Bruenneck, Edward Georg Michaelis, Selina Greuel, Verena Heynol, Annika Lehmann, et al. (+9)
64 [GO] 2021―Feb―07 Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection Lauren E. Merz, Kavita Mistry, Revital Freedman, Katherine L Jolley, Hae Soo Park, David M. Dorfman, et al. (+2)
65 [GO] 2021―Feb―07 Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS) Ho Pui Jeff Lam, Jayanthi Alamelu, James Brighouse, Owen Miller, Jonathan Lillie, Baba PD Inusa
66 [GO] 2021―Feb―06 Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19 Hanny Al-Samkari, Fei Song, Elizabeth M. Van Cott, David J. Kuter, Rachel P. Rosovsky
67 [GO] 2021―Feb―06 Filter Clotting with Continuous Renal Replacement Therapy in COVID-19 Rachel P. Rosovsky, Paul Endres, Soophia H Zhao, Scott Krinsky, Shananssa G Percy, Omer Kamal, et al. (+13)
68 [GO] 2021―Feb―06 Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19 Spyridoula Vasileiou, Manik Kuvalekar, Aster Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, et al. (+7)
69 [GO] 2021―Feb―06 Worldwide Examination of Patients with CLL Hospitalized for COVID-19 Lindsey E Roeker, Lydia Scarfo, Thomas Chatzikonstantinou, Pau Abrisqueta, Toby A. Eyre, Raul Cordoba, et al. (+147)
70 [GO] 2021―Feb―06 Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19 Michael Roderick Cook, Kaitlyn C Dykes, Katherine White, Jaeil Ahn, Nathan Cobb, Catherine Lai
71 [GO] 2021―Feb―06 Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis Samuel Rubinstein, Ryan C. Lynch, Aakash Desai, Catherine Stratton, Alokkumar Jha, Ziad Bakouny, et al. (+12)
72 [GO] 2021―Feb―06 Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital Anita Mazloom, Neil Nimkar, Sonal Paul, Ayanna Baptiste
73 [GO] 2021―Feb―06 COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study Delphine Rea, Michael J. Mauro, Jorge E. Cortes, Qian Jiang, Katia B Pagnano, Matilda Ongondi, et al. (+4)
74 [GO] 2021―Feb―06 Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience Jennifer Fields, Mary Brown, Chanell Grismore, Yadira Badwan, Susan Claster, Diane J. Nugent
75 [GO] 2021―Feb―06 The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives Ana I. Velazquez Manana, Urshila Durani, Robby Reynolds, Ashok Kumbamu, Devika G. Das, Martina C. Murphy, et al. (+3)
76 [GO] 2021―Feb―06 Impact on Mental Health, Disease Management and Socioeconomic Modifications in Hematological Patients during COVID-19 Pandemia in Italy Marianna De Muro, Sergio Amadori, Nicolina Rita Ardu, Elisabetta Cerchiara, Paolo De Fabritiis, Pasquale Niscola, et al. (+5)
77 [GO] 2021―Feb―06 Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic Gonzalo De Luna, Nicolas Lemonier, Alexis Aidan, Lea Bontemps, Manuel Hautefaye, Hadrien Diakonoff, et al. (+7)
78 [GO] 2021―Feb―06 Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study Nancy S. Green, Deepa Manwani, Kim Smith-Whitley, Banu Aygun, Abena Appiah-Kubi, Arlene Smaldone
79 [GO] 2021―Feb―06 Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry Roberta Demichelis, Martha Alvarado, Jule F Vasquez, Nancy Delgado, Cynthia Gómez, Karla Adriana Espinosa, et al. (+26)
80 [GO] 2021―Feb―06 Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients Surbhi Warrior, Elizabeth Behrens, Joshua Thomas, Priya Rajakumar, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
81 [GO] 2021―Feb―06 Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients Filip Ionescu, Girish B Nair, Ioana Petrescu, Anish S Konde, Markie Sue Zimmer, Nwabundo Anusim, et al. (+6)
82 [GO] 2021―Feb―06 Hematologic Characteristics of Surviving Versus Non-Surviving COVID-19 Patients in Critical Care Units: Inner-City Hospital Experience, Detroit, MI Nino Balanchivadze, Raef Fadel, Jawad Sheqwara, Philip Kuriakose
83 [GO] 2021―Feb―06 Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis George Goshua, Yiwen Liu, Matthew L. Meizlish, Rebecca Fine, Kejal Amin, Eric Chang, et al. (+9)
84 [GO] 2021―Feb―06 The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients Waleed Alduaij, Sarah Al-Youha, Ahmad Al-Serri, Sulaiman Almazeedi, Mohannad Al-Haddad, Mohammad H Jamal, Salman Al-Sabah
85 [GO] 2021―Feb―06 Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients Abi Vijenthira, Inna Gong, Thomas A Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, et al. (+13)
86 [GO] 2021―Feb―06 Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus Nicoletta Di Maio, Giovanna Russo, Susanna Barella, Gian Luca Forni, Raffaella Colombatti, Lucia Notarangelo, et al. (+38)
87 [GO] 2021―Feb―06 Leveraging Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest: Expanding Provider Education during a Pandemic Lisa M Shook, Christina Bennett Farrell, Cami Mosley, Lori E Crosby, Charles T. Quinn
88 [GO] 2021―Jan―14 Vaccinations in CLL: implications for COVID-19 Mazyar Shadman, Chaitra Ujjani
89 [GO] 2020―Dec―23 Antibody-induced procoagulant platelets in severe COVID-19 infection Karina Althaus, Irene Marini, Jan Zlamal, Lisann Pelzl, Anurag Singh, Helene Häberle, et al. (+11)
90 [GO] 2020―Dec―19 Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19-associated MIS-C Rachel Mariani, Huifei Liu
91 [GO] 2020―Dec―19 Expanding the toolbox to combat a pandemic Susan E. Prockop
92 [GO] 2020―Dec―03 COVID-19, plasma, and hypogammaglobulinemia Michael F. Murphy, Sunny Dzik
93 [GO] 2020―Dec―03 Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset Josée Perreault, Tony Tremblay, Marie-Josée Fournier, Mathieu Drouin, Guillaume Beaudoin-Bussières, Jérémie Prévost, et al. (+4)
94 [GO] 2020―Nov―17 How should we use convalescent plasma therapies for COVID-19? Erica Michelle Wood, Lise J Estcourt, Zoe McQuilten
95 [GO] 2020―Nov―06 Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society Dataset Ajai Chari, Mehmet Kemal Samur, Joaquin Martinez-Lopez, Gordon Cook, Noa Biran, Kwee L. Yong, et al. (+19)
96 [GO] 2020―Nov―05 COVID-19-induced atypical pulmonary lymphocytes Véronique Vergé, Ranya Soufan
97 [GO] 2020―Nov―04 Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19 Mo Yang, Huixia Deng, Liuming Yang, Liang Li, Jieyu Ye, Yucai Cheng, et al. (+3)
98 [GO] 2020―Nov―04 Thrombotic Complications in a Canadian Population of Critically Ill Patients with COVID-19 Simard Camille, Maral Koolian, Diana Escobar, Mark Blostein, Jed Lipes, Adelina Teona Avram, et al. (+4)
99 [GO] 2020―Nov―04 Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19 Grigoris Gerotziafas, Patrick Van Dreden, Loula Papageorgiou, Theodoros N Sergentanis, Meletios-Athanasios Dimopoulos, Ismail Elalamy
100 [GO] 2020―Nov―04 The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19 Lantarima Bhoopat, Anastasia Martynova, April Choi, Pattharawin Pattharanitima, Semi Han, Senxi Du, et al. (+5)
101 [GO] 2020―Nov―04 Thrombosis and Mortality in Pregnant Patients with COVID-19 Elizabeth Behrens, Surbhi Warrior, Joshua Thomas, Xavier Pombar, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
102 [GO] 2020―Nov―04 COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19 Isaac Chambers, Sanjana Dayal, Patrick Ten Eyck, Alicia Eustes, Grerk Sutamtewagul, Lori Rosenstein, et al. (+3)
103 [GO] 2020―Nov―04 The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19 Rodolfo Jiménez-Soto, Mercedes Aguilar-Soto, Roberta Demichelis
104 [GO] 2020―Nov―04 Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19 Harish Eswaran, Jamie Jarmul, Amy Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll
105 [GO] 2020―Nov―04 Mild Anemia As a Single Independent Predictor of Mortality in Patients with COVID-19 Douglas Tremblay, Joseph Rapp, Naomi Alpert, William Lieberman-Cribbin, John Mascarenhas, Emanuela Taioli, Saghi Ghaffari
106 [GO] 2020―Nov―04 Heparin Induced Thrombocytopenia in Patients with COVID-19 Surbhi Warrior, Elizabeth Behrens, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
107 [GO] 2020―Nov―04 Venous Thromboembolic Disease in Children Associated with COVID-19 Shalu Narang, Kavita Morparia, Prachi Sharma
108 [GO] 2020―Nov―04 Immune Thrombocytopenia Associated with COVID-19 - Case Series Ramil Fatkhullin, Vasily Shuvaev
109 [GO] 2020―Nov―04 Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study Patrick Van Dreden, Guillaume Voiriot, Alexandre Alabbadi, Ismail Elalamy, Loula Papageorgiou, Hélène Cost, et al. (+4)
110 [GO] 2020―Nov―04 Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study Alienor Xhaard, Constance Xhaard, Maud D'Aveni, Hélène Salvator, Marie-Laure Chabi-Charvillat, Tereza Coman, et al. (+13)
111 [GO] 2020―Nov―04 Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Ang Li, Nicole M. Kuderer, Jeremy L. Warner, Aakash Desai, Dimpy P. Shah, Julie Fu, et al. (+25)
112 [GO] 2020―Nov―04 Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy Ruimin Hong, Houli Zhao, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, et al. (+2)
113 [GO] 2020―Nov―04 COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH) Per Ljungman, Rafael De La Camara, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, Yves Beguin, et al. (+32)
114 [GO] 2020―Nov―04 Circulating Histone Levels Correlate with the Severity of COVID-19 and the Extent of Coagulation Activation and Inflammation Rebecca Jane Shaw, James Austin, Joseph Taylor, Tina Dutt, Guozheng Wang, Simon Timothy Abrams, Cheng Hock Toh
115 [GO] 2020―Nov―04 COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients Reyes María Martín-Rojas, Maite Chasco, Sara Casanova, Valeria Estefanía Delgado-Pinos, Gloria Perez-Rus, Patricia Duque, et al. (+3)
116 [GO] 2020―Nov―04 Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults William Beau Mitchell, Jennifer G. Davila, Janine Keenan, Jenai Jackson, Adit Tal, Kerry A Morrone, et al. (+3)
117 [GO] 2020―Nov―04 Newly Diagnosed Acute Lymphoblastic Leukemia in a Child with COVID-19 Complicated By MIS-C: A Case Report from Kuwait Fatemah Al-Haddad, Abdullah Ali, Danah Al-Sharrah, Suha Atyani, Hadeel Saleh, Ali M.A. Mullah-Ali
118 [GO] 2020―Nov―04 COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients Moayed Ibrahim, Priya Pal, Alex Niu, Kevin Zwezdaryk, Elise Tatje, Leta Ko, et al. (+19)
119 [GO] 2020―Nov―04 Whimsical (Waldenstrom's Macroglobulinemia Study Involving CArt-wheeL): A Global Patient-Derived Data Registry Capturing Treatment, Quality of Life and COVID-19 Data Ibrahim Tohidi-Esfahani, Andrew Warden, Elena Malunis, Peter Liburdi deNardis, Javier Haurat, Marita Black, et al. (+9)
120 [GO] 2020―Nov―04 Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis Cong Zhang, Jialan Shi, Changjun WU, Chunxu Wang, Xinyi Zhao, Jinming Zhang, et al. (+9)
121 [GO] 2020―Nov―04 The ACE2 Receptor for COVID-19 Entry Is Expressed on the Surface of Hematopoietic Stem/Progenitor Cells and Endothelial Progenitors As Well As Their Precursor Cells and Becomes Activated in Nlrp3 Inflammasome-Dependent Manner By Virus Spike Protein - a Potential Pathway Leading to a "Cytokine Storm" Magdalena Kucia, Kamila Bujko, Andrzej Ciechanowicz, Monika Cymer, Katarzyna Sielatycka, Janina Ratajczak, Mariusz Z Ratajczak
122 [GO] 2020―Nov―04 COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study Andrew Ip, Anthony Mato, Jordan Intrator, Nicholas P Howard, Alessandra Petrillo, Rosalba Vicioso, et al. (+6)
123 [GO] 2020―Nov―04 COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience Katia B Pagnano, Ana Carolina Mourão Toreli, Leila Martins Perobelli, Acy TS Quixada, Fernanda S Seguro, Israel Bendit, et al. (+19)
124 [GO] 2020―Nov―04 Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients Clarisse MARTINS Machado, Mariana Nassif Kerbauy, Iago Colturato, Leonardo Javier Arcuri, Ana Cláudia Ferrari dos Santos, Fernanda Rodrigues Silva, et al. (+5)
125 [GO] 2020―Nov―04 COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience Lindsay Wilde, Adam F. Binder, Matthew Carabasi, Joanne Filicko-O'Hara, John L. Wagner, Onder Alpdogan, et al. (+12)
126 [GO] 2020―Nov―04 COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality Alex Niu, Bo Ning, Francisco Socola, Hana Safah, Tim Reynolds, Moayed Ibrahim, et al. (+6)
127 [GO] 2020―Nov―04 COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting Saikrishna Gadde, Nikhil Manjunath, Ambuga Badari, John T. Cole, Rula Saeed
128 [GO] 2020―Nov―04 Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry Olga A. Gavrilina, Kristina Zakurdaeva, Vladimir I. Vorobyev, Anastasia N. Vasileva, Lev S. Butaev, Alena Sukhareva, et al. (+15)
129 [GO] 2020―Nov―04 Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report Badria M. Alghamdi, Ohoud F. Kashari
130 [GO] 2020―Nov―04 Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups Josep-Maria Ribera, Mireia Morgades, Rosa Coll, Jose Luis Lopez Lorenzo, Pau Montesinos, Rosario Varela, et al. (+15)
131 [GO] 2020―Nov―04 Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection Lana Mucalo, Amanda M. Brandow, Sadie F. Mason, Ashima Singh, Bradley W. Taylor, Katherine J. Woods, et al. (+2)
132 [GO] 2020―Nov―04 Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection Jesus Romero, Jorge Mazzini, Sarvari Venkata Yellapragada, Iberia R. Sosa, Gustavo A. Rivero
133 [GO] 2020―Nov―04 Autoimmune Hemolytic Anemia As Initial Presentation of COVID-19 Infection Gregorio Campos-Cabrera, Esther Mendez-Garcia, Maria Mora-Torres, Salvador Campos-Cabrera, Virgina Campos-Cabrera, Gabriel Garcia-Rubio, Jose-Luis Campos-Villagomez
134 [GO] 2020―Nov―04 Atypical Presentation of COVID-19 Infection Cory Mellon, Salma Ferouz, Tariq Mubarak, Isoken Koko
135 [GO] 2020―Nov―04 Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection Meera Sridharan, Aneel A. Ashrani, Dong Chen, Nahla M. Heikal, Ariela L. Marshall, Rajiv K. Pruthi
136 [GO] 2020―Nov―04 Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis? Félix Gibrant Marquez, Santiago Riviello-Goya, Angel Gabriel Vargas Ruiz, Edgar Ortíz Brizuela, Fernando Gil López, Alfredo Gutierrez Marín, et al. (+4)
137 [GO] 2020―Nov―04 Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy Daniel I. Nathan, Douglas Tremblay, Santiago Thibaud, John Mascarenhas, Janice L. Gabrilove
138 [GO] 2020―Nov―04 ABO/Rh Blood Group and COVID-19 Infection Severity David J Hermel, Elisa Quiroz, Samantha R Bagsic, Carrie L. Costantini, Alan Saven, James R. Mason, et al. (+3)
139 [GO] 2020―Nov―04 Outcomes of Patients with Hematologic Malignancies and COVID-19 Infection: A Report from the ASH Research Collaborative Data Hub William A. Wood, Donna S. Neuberg, John Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, et al. (+8)
140 [GO] 2020―Nov―04 Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience Sarah Sewaralthahab, Hedy Smith
141 [GO] 2020―Nov―04 Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina Laurence Noisette, Mamatha Mandava, Mathew Gregoski, Shayla Bergmann
142 [GO] 2020―Nov―04 The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality Juan Jose Cerezo Manchado, Pável E Olivera, María Dolores Lopez Abellan, Desiree Campoy Castaño, César A Velasquez, Carlos Rodriguez Rojas, et al. (+7)
143 [GO] 2020―Nov―04 Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment Urshila Durani, Ana I. Velazquez Manana, Jori May, Marquita Nelson, Ze Zheng, Anurekha Gollapudi, et al. (+11)
144 [GO] 2020―Nov―04 Impact of a National Lockdown for COVID-19 on Morbidity and Mortality Among Children with Sickle Cell Anaemia at a Tertiary Care Hospital in Uganda Ruth Namazzi, Robert Opoka, Andrea L Conroy, Dibyadyuti Datta, Micheal Goings, Chandy C. John
145 [GO] 2020―Nov―04 COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait Ashima Singh, Amanda M. Brandow, Julie Panepinto
146 [GO] 2020―Nov―04 Hematology Consultations during the COVID-19 Pandemic at a University Medical Center Daniel C Choi, Madhav Seshadri, Maria T De Sancho
147 [GO] 2020―Nov―04 Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care Blake T. Langlais, Carolyn Mead-Harvey, Heidi E. Kosiorek, Gina L. Mazza, Ruben Mesa, Jeanne M. Palmer, Amylou C. Dueck
148 [GO] 2020―Nov―04 A Survey of Survival Status of 601 Hemophilia Patients in Guangdong Region during COVID-19 Pandemic: Investigation and Implications Lei Meng, Jing Sun, Yufang Xun, Huiping Li, Zhuqin Liu, Xiaoqin Feng, Xuan Zhou
149 [GO] 2020―Nov―04 The Challenge of Recruiting Convalescent Plasma Donors during the COVID-19 Pandemic: Preliminary Results from a Single Center in Midwest Brazil Maria do Rosario Ferraz Roberti, Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Maria Cunha Ribeiro Morelli, et al. (+5)
150 [GO] 2020―Nov―04 Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study Nina Khanna, Maja Weisser, Anemone Hedstueck, Sarah Tschudin Sutter, Sandra Roesch, Manuel Battegay, et al. (+15)
151 [GO] 2020―Nov―04 A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients Hani Al Hashmi, Deia Alawami, Syed Ziauddin A Zaidi, Nawal F Alshehry, Hazza A. Alzahrani, Abdul Rehman Z Zaidi, et al. (+15)
152 [GO] 2020―Nov―04 Correlation between ABO Blood Groups and Disease Severity and Mortality in Hospitalized COVID-19 Patients Aula Ramo, Harshita Mehrotra, Ifeoma Onwubiko, Jawad Sheqwara, Zaher K. Otrock
153 [GO] 2020―Nov―04 Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients Gwendolyn Ho, Jennifer R Dusendang, Julie Schmittdiel, Juraj Kavecansky, Jahan Tavakoli, Ashok Pai
154 [GO] 2020―Nov―04 Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients Farah Ashraf, Anita Mazloom, Neil Nimkar, Nisha Patel, Amardeep Kalsi, Angelica Singh, et al. (+10)
155 [GO] 2020―Nov―04 Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients Cristina Sanz, Anabel Faundez, Anna García Carulla, Marta Rodriguez Aliberas, Anny Coromoto, Arturo Pereira
156 [GO] 2020―Nov―04 Impact of Blood Group Type on Severity of Disease in COVID-19 Patients Shivani Rao, Surbhi Warrior, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
157 [GO] 2020―Nov―04 Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients Eleni Gavriilaki, Styliani Kokoris, Tasoula Touloumenidou, Evdoxia Koravou, Maria Koutra, Vassiliki Karali, et al. (+16)
158 [GO] 2020―Nov―04 The Correlation between Absolute Lymphocyte Counts and Clinical Outcomes in COVID-19 Patients Mayer Goldberg, Madhumati Kalavar, Joseph Giovanetti
159 [GO] 2020―Nov―04 Thrombocytopenia Associated with Increase in Disease Severity and Mortality in COVID-19 Patients Ranjit Banwait, Aya Marachi, Uma G. Iyer
160 [GO] 2020―Nov―04 The Potential Role of Therapeutic Dose of Low Molecular Weight Heparin (LWMH) to Attenuate Hyper-Inflammatory State in Hospitalized COVID-19 Patients Mohsin Sheraz Mughal, Ikwinder Preet Kaur, Ali R. Jaffery, Chang Wang, Muhammad Asif, Anthony J. Ricca, et al. (+3)
161 [GO] 2020―Nov―04 Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital Patricia Gomez-Rosas, Marina Marchetti, Eleonora Sanga, Sara Gamba, Cristina Verzeroli, Laura Russo, et al. (+7)
162 [GO] 2020―Nov―04 Thrombotic Events in COVID-19 Patients and Its Comparison with Other Non-Sars-Cov-2 Respiratory Viruses Jing Yuan Tan, Chuen Wen Tan, Wan Hui Wong, Edwin Philip Conceicao, Ian Matthias Ng, May Anne Cheong, et al. (+3)
163 [GO] 2020―Nov―04 Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System Poy P. Theprungsirikul, Sunil E. Saith
164 [GO] 2020―Nov―04 Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry Dimitrios Giannis, Steven L. Allen, Anne Davidson, Galina S. Marder, Sarah Flint, David Garrett, et al. (+8)
165 [GO] 2020―Nov―04 Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation Rich Kodama, Amardeep Kalsi, Angelica Singh, Nivetha Vishnuvardhan, Neil Nimkar, Sonal Paul, et al. (+10)
166 [GO] 2020―Nov―04 Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation Damian Ratano, Caragata Rebecca, Eddy Fan, Ewan C Goligher, Rita Selby, Niall D Ferguson, et al. (+2)
167 [GO] 2020―Nov―04 Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance Catarina Maia, Esperanza Martín-Sánchez, Juan José Garcés, Ascensión López-Diaz de Cerio, Susana Inogés, Manuel Landecho, et al. (+16)
168 [GO] 2020―Nov―04 Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease Nwabundo Anusim, Ruby Gupta, Hycienth O Ahaneku, Candace Franklin, Savitha Balaraman, Marianne Terese Huben, Ishmael Jaiyesimi
169 [GO] 2020―Nov―04 Use of Convalescent Plasma in COVID-19 Patients: Guayaquil, Ecuador Experience. Carlos Plaza, Brener Sabando, Yaira Loor Morán, Maria Alejandra Posligua, Luis Layedra, Jorge William Oliveros-Alvear
170 [GO] 2020―Nov―04 Anticoagulation Management and Outcomes in Covid-19 Patients:a Multi-Center Retrospective Cohort Study Jasmeet Kaur, Anupam A Sule, Tracy Koehler, Geetha Krishnamoorthy, Jennifer DeLongpre
171 [GO] 2020―Nov―04 Higher Tissue Factor (TF) Expression in the Lungs of COVID-19 Pneumonia Patients Than Patients with Acute Respiratory Distress Syndrome: Association with Thrombi Formation Sandeep Subrahmanian, Alain Borczuk, Steven P. Salvatore, Jeffrey Laurence, Jasimuddin Ahamed
172 [GO] 2020―Nov―04 Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications Wolfgang Dummer, Vadim V. Markovtsov, Sandra Tong, Esteban Masuda
173 [GO] 2020―Nov―04 Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City Christian Salib, Pallavi Khattar, Jinjun Cheng, Julie Teruya-Feldstein
174 [GO] 2020―Nov―04 Does Thrombocytopenia Truly Correlate with COVID-19 Severity? Caroline Hana, Samar Aboulenain, Nakeya Dewaswala, Vijay Narendran
175 [GO] 2020―Nov―04 Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease Mahmoud A.Z. Abdelaal, Dyala Abdelrahman, Mahir Cengiz, Hakan Yavuzer, Serap Yavuzer, Ivy Bien, et al. (+9)
176 [GO] 2020―Nov―04 Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease Mari Thomas, Nishkantha Arulkumaran, David Brearley, Ferras Alwan, Deepak Singh, Michael P Lunn, et al. (+8)
177 [GO] 2020―Nov―04 COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic Talat Almukhtar, Julio Hajdenberg, Gurjot Garcha
178 [GO] 2020―Nov―04 Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study) Massimiliano Bonifacio, Gianni Binotto, Mario Tiribelli, Maria Cristina Miggiano, Malgorzata Monika Trawinska, Luigi Scaffidi, et al. (+14)
179 [GO] 2020―Nov―04 Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty Ana Belen Moreno-Castaño, Sara Fernandez, Marta Palomo, Patricia Molina, Julia Martinez-Sanchez, Sergi Torramade-Moix, et al. (+12)
180 [GO] 2020―Nov―04 Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity? Imran K Tailor, Nawal F Alshehry, Kamran Sabir, Abdul Rehman Z Zaidi, Mohammed Marei, Ibraheem Motabi, et al. (+3)
181 [GO] 2020―Nov―04 CD28 Expression Distinguishes Plasma Cell Fate in Pediatric Patients Suffering from COVID-19/Kawasaki's Disease Vs MIS-C Adam Utley, Kelvin P. Lee, Mark Hicar
182 [GO] 2020―Nov―04 VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study Daria V Madeeva, Jana Christian, George Goshua, Hyung J. Chun, Alfred Ian Lee, Alexander B Pine
183 [GO] 2020―Nov―04 Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study Mark Crowther, David A. Garcia, Jason Hill, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
184 [GO] 2020―Nov―04 Successful Outcomes of Children Simultaneously Diagnosed with Acute Myeloid Leukemia and Covid-19: The Role of a Mild Chemotherapeutic Induction Regimen Mecneide Mendes Lins, Juliana Teixeira Costa, Alayde Vieira Wanderley, Adriana Seber, Cinthya Rocha, Luciana Nunes Silva, et al. (+4)
185 [GO] 2020―Nov―04 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Hematologic Patients: Experience at the Hospital Attending More Patients in Spain Alba Cabirta, Macarena Izuzquiza, Isabel Ruiz-Camps, David Valcarcel, Eva Catala, M Moraima Jimenez, et al. (+11)
186 [GO] 2020―Nov―04 Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience Sabrina L. Browning, Michael Gormally, Neima Briggs, Muyi Li, Alan Zakko, Maudry Laurent-Rolle, et al. (+11)
187 [GO] 2020―Nov―04 Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2 Fernando Pérez-Jacobo, Luis Villela Villela, Edgar Velásquez-Vega, Jesús Hernández, Melani Otañez, Mónica Arellano-Mendoza, et al. (+23)
188 [GO] 2020―Nov―04 Antibody Response Against Sars-Cov-2 in Convalescent Plasma Donors: Preliminary Results from a Single Center in Midwest Brazil Maria do Rosario Ferraz Roberti, Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Francielle Barreto Machado Candido, et al. (+4)
189 [GO] 2020―Nov―04 Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases Chiara Cattaneo, Valeria Cancelli, Chiara Pagani, Alessandra Tucci, Giuseppe Rossi, Luisa Imberti, et al. (+6)
190 [GO] 2020―Nov―04 Detailed Immunophenotypic Profiling of Peripheral Blood Immune Cells in Patients with Hematologic Malignancies after Sars-Cov-2 Infection Forat Lutfi, Jonathan Siglin, Gabriela Sanchez-Petitto, Ali Bukhari, David Gottlieb, Dong Won Kim, et al. (+8)
191 [GO] 2020―Nov―04 Sars-Cov-2 Infection and Systemic Light Chain Amyloidosis: The International Society of Amyloidosis' Survey Paolo Milani, Vaishali Sanchorawala, Ramon Lecumberri, Sunil Saith, Mathew S. Maurer, M. Teresa Cibeira, et al. (+3)
192 [GO] 2020―Nov―04 Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry Pilar Martínez, Tomás Palanques Pastor, Jose Luiz Lopez Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez-Macías, Isabel Cano, et al. (+36)
193 [GO] 2020―Nov―04 Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group Rebeca Bailén, Mi Kwon, Beatriz Aguado, Rafael F. Duarte, Maria Calbacho, Anabelle Chinea, et al. (+12)
194 [GO] 2020―Nov―04 Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group Jose M. Moraleda, Carmelo Carlo-Stella, David Garcia-Bernal, Ruben Jara Rubio, Enriqueta Andreu, Eleonora Calabretta, et al. (+18)
195 [GO] 2020―Nov―04 Inflammation Drives Coagulopathies in Sars-Cov-2 Patients Martha MS Sim, Meenakshi Banerjee, Melissa Hollifield, Hammodah Alfar, Xian Li, Alice Thornton, et al. (+9)
196 [GO] 2020―Nov―04 Evidence of Microangiopathy in Children with Sars-Cov-2 Regardless of Clinical Presentation Caroline Diorio, Kevin O McNerney, Michele P. Lambert, Michele Paessler, Julie Chase, Kandace Gollomp, et al. (+18)
197 [GO] 2020―Nov―04 Impaired Sars-Cov-2 Specific Antibody Responses in Patients Treated with Anti-CD20 Antibodies Alessandra Sottini, Luisa Imberti, Simone Paghera, Vanessa Previcini, Chiara Cattaneo, Eugenia Quiros-Roldan, et al. (+7)
198 [GO] 2020―Nov―04 Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings Mansi R Shah, Imraan Jan, Jeremy Johns, Kuldip Singh, Pallavi Kumar, Norma Belarmino, et al. (+7)
199 [GO] 2020―Nov―04 Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan Area Stephanie Berg, Seo-Hyun Kim, Sonam Patel, Priya Rajakumar, Elizabeth Jane Elliott, Candice Schwartz, et al. (+32)
200 [GO] 2020―Nov―04 Analysis of Sars-Cov-2-Associated Proteins Identify Tank-Binding Kinase-1 As an Immunotherapeutic Target in Multiple Myeloma Arghya Ray, Ting DU, Krishan Chauhan, Yan Song, Dharminder Chauhan, Kenneth Anderson
201 [GO] 2020―Nov―04 Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience Carlos Galvez, Imran Nizamuddin, Emily Tuchman, Peter Doukas, Neha Reddy, Jessica K. Altman, et al. (+15)
202 [GO] 2020―Nov―04 Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study Cristina De Ramón, Jose Angel Hernandez-Rivas, Jose Antonio Rodríguez García, Enrique M. Ocio, María Teresa Gómez-Casares, Javier López Jiménez, et al. (+13)
203 [GO] 2020―Nov―04 How We Did Bone Marrow Transplants amidst the COVID19 Pandemic Kishore Kumar, Durai Prabhu, Dharani Devi, Dilshada Pulikkal, Joshua Daniel, Chezhian Subash
204 [GO] 2020―Nov―04 Impact of the COVID19 Pandemic on Admissions and Emergency Department Visits of Adults with Sickle Cell Disease Alice J. Cohen
205 [GO] 2020―Nov―04 Maximising Capacity and Saving Cost in an Outpatient Chemotherapy Centre during a Pandemic: A Quality Improvement Project Ednajoy Ngo, Cheng Ean Chee, Melinda Khoo, Yee Mei Lee, Belinda Tan, Yen-Lin Chee, Wei-Ying Jen
206 [GO] 2020―Nov―04 Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times Richard Curtis Godby, Ashton Kornbrust, Denis Noubouossie, Jose Lima, Marisa B. Marques, Rance C Siniard
207 [GO] 2020―Nov―04 Outcome of Severe Aplastic Anemia Treated with Low Dose Immunosuppression in Resource Limited World during Pandemic: Single Center Experience from Myanmar Aye Aye Gyi, Khin Thida Htut, Yin Nwe Han, Mie Mie Khine, Hnin Mya Thandar, Yi Mon Thant
208 [GO] 2020―Oct―29 Targeting complement activation in COVID-19 Hrishikesh S. Kulkarni, John P. Atkinson
209 [GO] 2020―Oct―28 Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients Abi Vijenthira, Inna Y. Gong, Thomas A Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, et al. (+13)
210 [GO] 2020―Oct―26 SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic Use and Target Conserved Regions of Membrane Protein Michael D. Keller, Katherine M. Harris, Mariah A. Jensen-Wachspress, Vaishnavi Kankate, Haili Lang, Christopher Andrew Lazarski, et al. (+27)
211 [GO] 2020―Sep―22 Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease Thomas Hueso, Cécile Pouderoux, Hélène Péré, Anne-Lise Beaumont, Laure-Anne Raillon, Florence Ader, et al. (+31)
212 [GO] 2020―Sep―10 Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19 Eugenio D. Hottz, Isaclaudia G. Azevedo-Quintanilha, Lohanna Palhinha, Lívia Teixeira, Ester A. Barreto, Camila R. R. Pão, et al. (+6)
213 [GO] 2020―Sep―10 COVID-19 concerns aggregate around platelets Elisabeth M. Battinelli
214 [GO] 2020―Sep―03 A NET-thrombosis axis in COVID-19 Andrés Hidalgo
215 [GO] 2020―Sep―03 When CLL meets COVID-19 Emili Montserrat
216 [GO] 2020―Sep―02 Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition Jia Yu, Xuan Yuan, Hang Chen, Shruti Chaturvedi, Evan M. Braunstein, Robert A. Brodsky
217 [GO] 2020―Sep―01 No evidence of SARS-CoV-2 transfusion-transmission despite RNA detection in blood donors showing symptoms after donation Pierre Cappy, Daniel Candotti, Virginie Sauvage, Quentin Lucas, Laure Boizeau, Johanna Gomez, et al. (+6)
218 [GO] 2020―Aug―14 Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome Won Sok Lee, Elizabeth Margolskee
219 [GO] 2020―Aug―14 Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient Gregoire Stalder, Lorenzo Alberio
220 [GO] 2020―Aug―07 Post-discharge thrombosis and hemorrhage in patients with COVID-19 Rushad Patell, Thomas Bogue, Anita G Koshy, Poorva Bindal, Mwanasha Merrill, William C Aird, et al. (+2)
221 [GO] 2020―Aug―06 Convalescent plasma to treat COVID-19 Evan M. Bloch
222 [GO] 2020―Aug―06 COVID-19 and the Coombs test Jeanne E. Hendrickson, Christopher A. Tormey
223 [GO] 2020―Aug―03 Post-discharge venous thromboembolism following hospital admission with COVID-19 Lara N Roberts, Martin Brunel Whyte, Loizos Georgiou, Gerard Giron, Julia Czuprynska, Catherine Rea, et al. (+4)
224 [GO] 2020―Jul―23 COVID-19 coagulopathy, thrombosis, and bleeding Noel C. Chan, Jeffrey I. Weitz
225 [GO] 2020―Jul―20 Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience Anthony R. Mato, Lindsey Elizabeth Roeker, Nicole Lamanna, John Allan, Lori Ann Leslie, John M. Pagel, et al. (+56)
226 [GO] 2020―Jun―29 Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome Elizabeth A Middleton, Xue-Yan He, Frederik Denorme, Robert A. Campbell, David Ng, Steven P. Salvatore, et al. (+18)
227 [GO] 2020―Jun―23 Platelet Gene Expression and Function in COVID-19 Patients Bhanu Kanth Manne, Frederik Denorme, Elizabeth A Middleton, Irina Portier, Jesse W Rowley, Chris J. Stubben, et al. (+8)
228 [GO] 2020―Jun―23 Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion Xinyi Xia, Kening Li, Lingxiang Wu, Zhihua Wang, Mengyan Zhu, Bin Huang, et al. (+19)
229 [GO] 2020―Jun―19 Red cell bound antibodies and transfusion requirements in hospitalized patients with COVID-19 Alessandra Berzuini, Cristiana Bianco, Cinzia Paccapelo, Francesco Bertolini, Giuliana Gregato, Alessandra Cattaneo, et al. (+13)
230 [GO] 2020―Jun―19 Use of Convalescent Plasma in Hospitalized Patients with Covid-19 - Case Series Livia Hegerova, Ted Gooley, Kelly A Sweerus, Cynthia L Maree, Neil Bailey, Megumi Bailey, et al. (+14)
231 [GO] 2020―Jun―19 CHRONIC LYMPHOCYTIC LEUKEMIA MANAGEMENT IN ITALY DURING THE COVID-19 PANDEMIC. A CAMPUS CLL REPORT Antonio Cuneo, Lydia Scarfo, Gianluigi Reda, Marzia Varettoni, Francesca Maria Quaglia, Monia Marchetti, et al. (+12)
232 [GO] 2020―Jun―18 Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic Robert Sheppard Nickel, Stefanie Margulies, Brittany Frazer, Naomi L. C. Luban, Jennifer Webb
233 [GO] 2020―Jun―18 Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection Klaas Dewaele, Rowan Claeys
234 [GO] 2020―Jun―18 Morphological changes in a case of SARS-CoV-2 infection John R. Jones, Robin Ireland
235 [GO] 2020―Jun―11 Hypersegmented granulocytes and COVID-19 infection Christian Salib, Julie Teruya-Feldstein
236 [GO] 2020―Jun―03 House Calls for Stem Cell Transplants During the COVID-19 Pandemic. Anthony D Sung, Krista R. Nichols, Nelson J. Chao
237 [GO] 2020―Jun―03 COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection Hanny Al-Samkari, Rebecca S Karp Leaf, Walter H Dzik, Jonathan CT Carlson, Annemarie E Fogerty, Anem Waheed, et al. (+7)
238 [GO] 2020―May―28 COVID-19 and SCA: an old friend comes to the rescue Enrico M. Novelli
239 [GO] 2020―May―28 Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study Douglas Tremblay, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina Justine Kessler, Sangeetha Venugopal, et al. (+13)
240 [GO] 2020―May―27 Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19? Matthew J Frigault, Sarah Nikiforow, Michael Mansour, Zhen-Huan Hu, Mary M Horowitz, Marcie Riches, et al. (+5)
241 [GO] 2020―Apr―27 COVID-19 and its implications for thrombosis and anticoagulation Jean Marie Connors, Jerrold H Levy
242 [GO] 2020―Apr―17 The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients Steven P Treon, Jorge Castillo, Alan P Skarbnik, Jacob D Soumerai, Irene M Ghobrial, Maria Luisa Guerrera, et al. (+2)
243 [GO] 2020―Apr―13 Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic Michael R DeBaun
244 [GO] 2020―Apr―10 ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic Joachim Yahalom, Bouthaina S. Dabaja, Umberto Ricardi, Andrea Ng, N. George Mikhaeel, Ivan Richter Vogelius, et al. (+4)


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.132 sec